Active Ingredient History
Lenograstim is a recombinant granulocyte colony-stimulating factor which functions as an immunostimulator. It is developed by Chugai Pharmaceuticals under the brand name Granocyte. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Neutropenia (approved 2002)
Adenocarcinoma of Lung (Phase 2)
Allografts (Phase 3)
Alzheimer Disease (Phase 2)
Amyloidosis (Phase 1)
Anemia (Phase 2)
Anemia, Aplastic (Phase 2)
Anemia, Refractory (Phase 2)
Anemia, Sickle Cell (Phase 1/Phase 2)
Ascites (Phase 1/Phase 2)
Astrocytoma (Phase 1)
Autoimmune Diseases (Phase 3)
beta-Thalassemia (Phase 1/Phase 2)
Bile Duct Neoplasms (Phase 2)
Biliary Atresia (Phase 2)
Biomarkers (Phase 1)
Bone Marrow Diseases (Phase 4)
Bone Marrow Failure Disorders (Phase 2)
Bone Neoplasms (Phase 2)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 4)
Breast Neoplasms, Male (Phase 2)
Bronchiectasis (Phase 1)
Burkitt Lymphoma (Phase 2)
Carcinoma, Embryonal (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 4)
Carcinoma, Ovarian Epithelial (Phase 3)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 3)
Central Nervous System Neoplasms (Phase 1)
Chemotherapy, Adjuvant (Phase 4)
Chemotherapy-Induced Febrile Neutropenia (Phase 4)
Cholangiocarcinoma (Phase 2)
Choriocarcinoma (Phase 3)
Choroid Plexus Neoplasms (Phase 1)
Chronic Limb-Threatening Ischemia (Phase 1/Phase 2)
Colonic Neoplasms (Phase 3)
Colony-Stimulating Factors (Phase 3)
Colorectal Neoplasms (Phase 3)
Congenital Bone Marrow Failure Syndromes (Phase 2)
Coronary Artery Disease (Phase 1)
Cost-Benefit Analysis (Phase 4)
Cost of Illness (Phase 3)
COVID-19 (Phase 2)
Crohn Disease (Phase 2)
Cystic Fibrosis (Phase 2)
Diabetes Mellitus (Phase 1/Phase 2)
Diabetes Mellitus, Type 1 (Phase 2)
Diabetic Neuropathies (Phase 1)
Drug Therapy (Phase 3)
Embryonic Development (Phase 4)
Endodermal Sinus Tumor (Phase 3)
Endometrial Neoplasms (Phase 3)
Endometriosis (Phase 2)
End Stage Liver Disease (Phase 1/Phase 2)
Enterocolitis, Necrotizing (Phase 1/Phase 2)
Ependymoma (Phase 1)
Esophageal Neoplasms (Phase 3)
Fallopian Tube Neoplasms (Phase 2)
Fanconi Anemia (Phase 2)
Febrile Neutropenia (Phase 4)
Feeding and Eating Disorders (Phase 1/Phase 2)
Fertilization in Vitro (Phase 4)
Fever (Phase 3)
Filgrastim (Phase 4)
General Surgery (Phase 3)
Genital Neoplasms, Female (Phase 4)
Geriatrics (Phase 2)
Germinoma (Phase 3)
Glioblastoma (Phase 2)
Glioma (Phase 1)
Gliosarcoma (Phase 2)
Granulocyte Colony-Stimulating Factor (Phase 4)
Hamartoma (Phase 2)
Head and Neck Neoplasms (Phase 2)
Healthy Volunteers (Phase 3)
Hemangiosarcoma (Phase 1)
Hematologic Neoplasms (Phase 4)
Hematology (Phase 2)
Hematopoietic Stem Cell Mobilization (Phase 4)
Hematopoietic Stem Cell Transplantation (Phase 4)
Hepatitis, Alcoholic (Phase 4)
Hepatoblastoma (Phase 1)
Hodgkin Disease (Phase 4)
Hypoglycemia (Phase 1/Phase 2)
Idiopathic Pulmonary Fibrosis (Phase 1/Phase 2)
Immune Checkpoint Inhibitors (Phase 2)
Immunity, Humoral (Phase 1)
Induction Chemotherapy (Phase 3)
Infections (Phase 1)
Infertility (Phase 4)
Infertility, Female (Phase 4)
Leiomyosarcoma (Phase 3)
Lenograstim (Phase 4)
Leukemia (Phase 4)
Leukemia, Biphenotypic, Acute (Phase 1/Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Lymphoid (Phase 2)
Leukemia-Lymphoma, Adult T-Cell (Phase 2)
Leukemia, Monocytic, Acute (Phase 2/Phase 3)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 2)
Leukemia, Prolymphocytic (Phase 2)
Liver Cirrhosis (Phase 3)
Lung Diseases (Phase 3)
Lung Neoplasms (Phase 4)
Lymphoma (Phase 4)
Lymphoma, AIDS-Related (Phase 1)
Lymphoma, B-Cell (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 3)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 4)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Cutaneous (Phase 1)
Lymphoma, T-Cell, Peripheral (Phase 1)
Lymphopenia (Phase 2)
Malnutrition (Phase 3)
Medulloblastoma (Phase 2)
Melanoma (Phase 2/Phase 3)
Meningioma (Phase 1)
Multiple Myeloma (Phase 3)
Multiple Sclerosis, Relapsing-Remitting (Phase 3)
Muscular Diseases (Phase 1)
Musculoskeletal Diseases (Phase 1)
Mutation (Phase 1)
Myasthenia Gravis (Phase 1)
Mycobacterium Infections, Nontuberculous (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 3)
Myocardial Infarction (Phase 2)
Myocardial Ischemia (Phase 2)
Nasopharyngeal Carcinoma (Phase 3)
Neoadjuvant Therapy (Phase 2)
Neoplasm Metastasis (Phase 1)
Neoplasms (Phase 4)
Neoplasms by Histologic Type (Phase 1)
Neoplasms, Germ Cell and Embryonal (Phase 3)
Neoplasms, Neuroepithelial (Phase 1)
Neuroblastoma (Phase 1)
Neuroectodermal Tumors, Primitive (Phase 1)
Neuromyelitis Optica (Phase 2/Phase 3)
Neutropenia (Phase 4)
Oligodendroglioma (Phase 1)
Osteosarcoma (Phase 1)
Ovarian Diseases (Phase 4)
Ovarian Neoplasms (Phase 4)
Pain (Phase 1/Phase 2)
Pancreatic Neoplasms (Phase 3)
Papillomaviridae (Phase 2)
Paraganglioma (Phase 1)
Patient Participation (Phase 3)
Pharmacokinetics (Phase 1)
Pharmacology, Clinical (Phase 1)
Pinealoma (Phase 1)
Plasma (Phase 3)
Postmenopause (Phase 1)
Primary Immunodeficiency Diseases (Phase 1/Phase 2)
Primary Myelofibrosis (Phase 3)
Progression-Free Survival (Phase 3)
Prostatic Neoplasms (Phase 4)
Prostheses and Implants (Phase 2)
Pulmonary Alveolar Proteinosis (Phase 1)
Pulmonary Disease, Chronic Obstructive (Phase 1/Phase 2)
Quality of Life (Phase 3)
Rare Diseases (Phase 2/Phase 3)
Rectal Neoplasms (Phase 3)
Respiratory Distress Syndrome (Phase 1)
Retinoblastoma (Phase 2)
Rhabdoid Tumor (Phase 1)
Rhabdomyosarcoma (Phase 2)
Sarcoma (Phase 3)
Sarcoma, Clear Cell (Phase 1)
Sarcoma, Ewing (Phase 2)
Scleroderma, Systemic (Phase 3)
Seminoma (Phase 3)
Severe Acute Respiratory Syndrome (Phase 2)
Severe Combined Immunodeficiency (Phase 1/Phase 2)
Small Cell Lung Carcinoma (Phase 3)
Spine (Phase 3)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
ST Elevation Myocardial Infarction (Phase 3)
Stem Cells (Phase 1)
Stevens-Johnson Syndrome (Phase 2/Phase 3)
Stiff-Person Syndrome (Phase 1/Phase 2)
Stomach Neoplasms (Phase 2)
Teratoma (Phase 3)
Testicular Neoplasms (Phase 2)
Therapeutic Equivalency (Phase 1)
Thrombocytopenia (Phase 2)
Triple Negative Breast Neoplasms (Phase 3)
Ureteral Neoplasms (Phase 3)
Urethral Neoplasms (Phase 3)
Urinary Bladder Neoplasms (Phase 3)
Uterine Cervical Neoplasms (Phase 4)
Uterine Neoplasms (Phase 3)
Vasculitis (Phase 1)
Wilms Tumor (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
